Current Issue


Screening recommended to detect metabolic risk for ASCVD, type 2 diabetes

The Endocrine Society recently updated its guidance on primary prevention of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes in those at metabolic risk.

Diabetes patients with healthy lifestyles appear to have low, no excess CVD risk, study finds

An accompanying editorial called for broader international efforts to target cardiovascular risk through programs that encourage healthy lifestyles.

Different diabetes phenotypes associated with varying prevalence of complications

Patients were categorized into five groups: mild age-related diabetes, mild obesity-related diabetes, severe autoimmune diabetes, severe insulin-resistant diabetes, and severe insulin-deficient diabetes.

MKSAP quiz: Coronary artery disease and type 2 diabetes

This month's quiz asks readers to evaluate a 64-year-old man with type 2 diabetes who has undergone coronary angiography after presenting with progressive exertional chest pain and shortness of breath.

Spotlight on genetic risks

One study found that counseling about genetic risk for diabetes does not lead at-risk patients to lose weight, while another determined that advice on fat consumption does not need to be individualized based on genetic risk.

Intensive treatment of hyperglycemia during ischemic stroke did not improve functional recovery

In patients with acute ischemic stroke and hyperglycemia, a target glucose level of 80 to 130 mg/dL was associated with more hypoglycemia and no difference in functional outcomes compared to a target of 80 to 179 mg/dL.

SGLT-2 inhibitors not associated with increased risk for severe UTIs

An accompanying editorial said that while the study's finding is reassuring, it should be considered with caution, especially since high-risk patients and those with previous urinary tract infections (UTIs) were excluded.

First noninjection treatment for severe hypoglycemia approved

The nasal powder is indicated for the emergency treatment of severe hypoglycemia in patients with diabetes ages 4 years and older.